HomeMIRM • NASDAQ
add
Mirum Pharmaceuticals Inc
Previous close
$25.60
Day range
$25.66 - $26.22
Year range
$23.14 - $35.56
Market cap
1.22B USD
Avg Volume
445.02K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 69.55M | 149.24% |
Operating expense | 77.12M | 33.95% |
Net income | -35.66M | 2.12% |
Net profit margin | -51.27 | 60.73% |
Earnings per share | -0.63 | 36.36% |
EBITDA | -27.09M | 17.81% |
Effective tax rate | -0.63% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 286.33M | 88.72% |
Total assets | 646.62M | 83.23% |
Total liabilities | 397.95M | 88.72% |
Total equity | 248.67M | — |
Shares outstanding | 47.00M | — |
Price to book | 4.81 | — |
Return on assets | -12.56% | — |
Return on capital | -14.37% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -35.66M | 2.12% |
Cash from operations | -16.62M | 51.51% |
Cash from investing | -2.00M | -107.47% |
Cash from financing | 1.78M | 640.12% |
Net change in cash | -16.73M | -115.74% |
Free cash flow | -18.12M | -61.61% |
About
Founded
2018
Headquarters
Website
Employees
264